1887

Journal of General Virology header logo

Volume 98, Issue 5

Moonlighting glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is required for efficient hepatitis C virus and dengue virus infections in human Huh-7.5.1 cells Free

Abstract

Hijacking of cellular biosynthetic pathways by human enveloped viruses is a shared molecular event essential for the viral lifecycle. In this study, the accumulating evidence of the importance of human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in the host secretory pathway led us to hypothesize that this moonlighting enzyme could play a key role in the lifecycle steps of two important members, hepatitis C virus (HCV) and dengue virus (DENV). We used short interfering RNA (siRNA)-mediated knockdown of human GAPDH in Huh-7.5.1 cells– both pre- and post-HCV infection– to demonstrate that GAPDH is a host factor for HCV infection. siRNA-induced GAPDH knockdown performed pre-HCV infection inhibits HCV core production in infected cells and leads to a decrease in infectivity of the HCV-infected cell supernatants. siRNA-induced GAPDH knockdown performed post-HCV infection does not have an effect on HCV core abundance in infected cells, but does lead to a decrease in infectivity of the HCV-infected cell supernatants. Exogenous expression of V5-tagged human GAPDH, pre- and post-infection, increases the infectivity of HCV-infected cell supernatants, suggesting a role for GAPDH during HCV post-replication steps. Interestingly, siRNA-induced GAPDH knockdown in HCV replicon-harbouring cells had no effect on viral RNA replication. Importantly, we confirmed the important role of GAPDH in the HCV lifecycle using Huh-7-derived stable GAPDH-knockdown clones. Finally, siRNA-induced GAPDH knockdown inhibits intracellular DENV-2 E glycoprotein production in infected cells. Collectively, our findings suggest that the moonlighting enzyme, GAPDH, is an important host factor for HCV infection, and they support its potential role in the DENV lifecycle.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): dengue virus (DENV) , glyceraldehyde-3-phosphate dehydrogenase (GAPDH) , hepatitis C virus (HCV) , host factors , host–virus interactions and viral lifecycle
© 2017 The Authors
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000754
2017-05-01
2024-04-26
Loading full text...

Full text loading...

/deliver/fulltext/jgv/98/5/977.html?itemId=/content/journal/jgv/10.1099/jgv.0.000754&mimeType=html&fmt=ahah

References

  1. Fischl W, Bartenschlager R. Exploitation of cellular pathways by dengue virus. Curr Opin Microbiol 2011; 14:470–475 [View Article][PubMed]
     [Google Scholar]
  2. Prussia A, Thepchatri P, Snyder JP, Plemper RK. Systematic approaches towards the development of host-directed antiviral therapeutics. Int J Mol Sci 2011; 12:4027–4052 [View Article][PubMed]
     [Google Scholar]
  3. Syed GH, Amako Y, Siddiqui A. Hepatitis C virus hijacks host lipid metabolism. Trends Endocrinol Metab 2010; 21:33–40 [View Article][PubMed]
     [Google Scholar]
  4. Popescu CI, Riva L, Vlaicu O, Farhat R, Rouillé Y et al. Hepatitis C virus life cycle and lipid metabolism. Biology 2014; 3:892–921 [View Article][PubMed]
     [Google Scholar]
  5. Chatel-Chaix L, Bartenschlager R, Virus- D. Dengue virus- and hepatitis C virus-induced replication and assembly compartments: the enemy inside—caught in the web. J Virol 2014; 88:5907–5911 [View Article][PubMed]
     [Google Scholar]
  6. Olmstead AD, Knecht W, Lazarov I, Dixit SB, Jean F. Human subtilase SKI-1/S1P is a master regulator of the HCV lifecycle and a potential host cell target for developing indirect-acting antiviral agents. PLoS Pathog 2012; 8:e1002468 [View Article][PubMed]
     [Google Scholar]
  7. Bartenschlager R, Lohmann V, Penin F. The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection. Nat Rev Microbiol 2013; 11:482–496 [View Article][PubMed]
     [Google Scholar]
  8. Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol 2013; 10:553–562 [View Article][PubMed]
     [Google Scholar]
  9. Acosta EG, Kumar A, Bartenschlager R. Revisiting dengue virus-host cell interaction: new insights into molecular and cellular virology. Adv Virus Res 2014; 88:1–109 [View Article][PubMed]
     [Google Scholar]
  10. Bryksin AV, Laktionov PP. Role of glyceraldehyde-3-phosphate dehydrogenase in vesicular transport from Golgi apparatus to endoplasmic reticulum. Biochemistry 2008; 73:619–625 [View Article][PubMed]
     [Google Scholar]
  11. Bar-Even A, Flamholz A, Noor E, Milo R. Rethinking glycolysis: on the biochemical logic of metabolic pathways. Nat Chem Biol 2012; 8:509–517 [View Article][PubMed]
     [Google Scholar]
  12. Tisdale EJ, Azizi F, Artalejo CR. Rab2 utilizes glyceraldehyde-3-phosphate dehydrogenase and protein kinase Cι to associate with microtubules and to recruit dynein. J Biol Chem 2009; 284:5876–5884 [View Article][PubMed]
     [Google Scholar]
  13. Robbins AR, Ward RD, Oliver C. A mutation in glyceraldehyde 3-phosphate dehydrogenase alters endocytosis in CHO cells. J Cell Biol 1995; 130:1093–1104 [View Article][PubMed]
     [Google Scholar]
  14. Harada N, Yasunaga R, Higashimura Y, Yamaji R, Fujimoto K et al. Glyceraldehyde-3-phosphate dehydrogenase enhances transcriptional activity of androgen receptor in prostate cancer cells. J Biol Chem 2007; 282:22651–22661 [View Article][PubMed]
     [Google Scholar]
  15. Raje CI, Kumar S, Harle A, Nanda JS, Raje M. The macrophage cell surface glyceraldehyde-3-phosphate dehydrogenase is a novel transferrin receptor. J Biol Chem 2007; 282:3252–3261 [View Article][PubMed]
     [Google Scholar]
  16. Backlund M, Paukku K, Daviet L, De Boer RA, Valo E et al. Posttranscriptional regulation of angiotensin II type 1 receptor expression by glyceraldehyde 3-phosphate dehydrogenase. Nucleic Acids Res 2009; 37:2346–2358 [View Article][PubMed]
     [Google Scholar]
  17. Rodríguez-Pascual F, Redondo-Horcajo M, Magán-Marchal N, Lagares D, Martínez-Ruiz A et al. Glyceraldehyde-3-phosphate dehydrogenase regulates endothelin-1 expression by a novel, redox-sensitive mechanism involving mRNA stability. Mol Cell Biol 2008; 28:7139–7155 [View Article][PubMed]
     [Google Scholar]
  18. Zhou Y, Yi X, Stoffer JB, Bonafe N, Gilmore-Hebert M et al. The multifunctional protein glyceraldehyde-3-phosphate dehydrogenase is both regulated and controls colony-stimulating factor-1 messenger RNA stability in ovarian cancer. Mol Cancer Res 2008; 6:1375–1384 [View Article][PubMed]
     [Google Scholar]
  19. Dollenmaier G, Weitz M. Interaction of glyceraldehyde-3-phosphate dehydrogenase with secondary and tertiary RNA structural elements of the hepatitis A virus 3' translated and non-translated regions. J Gen Virol 2003; 84:403–414 [View Article][PubMed]
     [Google Scholar]
  20. Li Y, Huang T, Zhang X, Wan T, Hu J et al. Role of glyceraldehyde-3-phosphate dehydrogenase binding to hepatitis B virus posttranscriptional regulatory element in regulating expression of HBV surface antigen. Arch Virol 2009; 154:519–524 [View Article][PubMed]
     [Google Scholar]
  21. Lin SS, Chang SC, Wang YH, Sun CY, Chang MF. Specific interaction between the hepatitis delta virus RNA and glyceraldehyde 3-phosphate dehydrogenase: an enhancement on ribozyme catalysis. Virology 2000; 271:46–57 [View Article][PubMed]
     [Google Scholar]
  22. Yang SH, Liu ML, Tien CF, Chou SJ, Chang RY. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) interaction with 3' ends of Japanese encephalitis virus RNA and colocalization with the viral NS5 protein. J Biomed Sci 2009; 16:40 [View Article][PubMed]
     [Google Scholar]
  23. Petrik J, Parker H, Alexander GJ. Human hepatic glyceraldehyde-3-phosphate dehydrogenase binds to the poly(U) tract of the 3' non-coding region of hepatitis C virus genomic RNA. J Gen Virol 1999; 80:3109–3113 [View Article][PubMed]
     [Google Scholar]
  24. Henderson B, Martin AC. Protein moonlighting: a new factor in biology and medicine. Biochem Soc Trans 2014; 42:1671–1678 [View Article][PubMed]
     [Google Scholar]
  25. Seidler NW. Basic biology of GAPDH. Adv Exp Med Biol 2013; 985:1–36 [View Article][PubMed]
     [Google Scholar]
  26. Perez-Hernandez D, Gutiérrez-Vázquez C, Jorge I, López-Martín S, Ursa A et al. The intracellular interactome of tetraspanin-enriched microdomains reveals their function as sorting machineries toward exosomes. J Biol Chem 2013; 288:11649–11661 [View Article][PubMed]
     [Google Scholar]
  27. Jung DW, Kim WH, Seo S, Oh E, Yim SH et al. Chemical targeting of GAPDH moonlighting function in cancer cells reveals its role in tubulin regulation. Chem Biol 2014; 21:1533–1545 [View Article][PubMed]
     [Google Scholar]
  28. Sheokand N, Malhotra H, Kumar S, Tillu VA, Chauhan AS et al. Moonlighting cell-surface GAPDH recruits apotransferrin to effect iron egress from mammalian cells. J Cell Sci 2014; 127:4279–4291 [View Article][PubMed]
     [Google Scholar]
  29. Blight KJ, Kolykhalov AA, Rice CM. Efficient initiation of HCV RNA replication in cell culture. Science 2000; 290:1972–1974 [View Article][PubMed]
     [Google Scholar]
  30. Blight KJ, McKeating JA, Rice CM. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 2002; 76:13001–13014 [View Article][PubMed]
     [Google Scholar]
  31. Lamarre D, Anderson PC, Bailey M, Beaulieu P, Bolger G et al. An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus. Nature 2003; 426:186–189 [View Article][PubMed]
     [Google Scholar]
  32. Randall G, Panis M, Cooper JD, Tellinghuisen TL, Sukhodolets KE et al. Cellular cofactors affecting hepatitis C virus infection and replication. Proc Natl Acad Sci USA 2007; 104:12884–12889 [View Article][PubMed]
     [Google Scholar]
  33. Allonso D, Andrade IS, Conde JN, Coelho DR, Rocha DC et al. Dengue virus NS1 protein modulates cellular energy metabolism by increasing glyceraldehyde-3-phosphate dehydrogenase activity. J Virol 2015; 89:11871–11883 [View Article][PubMed]
     [Google Scholar]
  34. Jordan TX, Randall G. Flavivirus modulation of cellular metabolism. Curr Opin Virol 2016; 19:7–10 [View Article][PubMed]
     [Google Scholar]
  35. Lessler J, Chaisson LH, Kucirka LM, Bi Q, Grantz K et al. Assessing the global threat from Zika virus. Science 2016; 353: [View Article][PubMed]
     [Google Scholar]
  36. Moradpour D, Evans MJ, Gosert R, Yuan Z, Blum HE et al. Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes. J Virol 2004; 78:7400–7409 [View Article][PubMed]
     [Google Scholar]
  37. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 2005; 102:9294–9299 [View Article][PubMed]
     [Google Scholar]
  38. Chen Y, Maguire T, Marks RM. Demonstration of binding of dengue virus envelope protein to target cells. J Virol 1996; 70:8765–8772[PubMed]
     [Google Scholar]
  39. Condotta SA, Martin MM, Boutin M, Jean F. Detection and in-cell selectivity profiling of the full-length West Nile virus NS2B/NS3 serine protease using membrane-anchored fluorescent substrates. Biol Chem 2010; 391:549–559 [View Article][PubMed]
     [Google Scholar]
  40. Martin MM, Condotta SA, Fenn J, Olmstead AD, Jean F. In-cell selectivity profiling of membrane-anchored and replicase-associated hepatitis C virus NS3-4A protease reveals a common, stringent substrate recognition profile. Biol Chem 2011; 392:927–935 [View Article][PubMed]
     [Google Scholar]
  41. Kato T, Furusaka A, Miyamoto M, Date T, Yasui K et al. Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient. J Med Virol 2001; 64:334–339 [View Article][PubMed]
     [Google Scholar]
  42. Medina F, Medina JF, Colón C, Vergne E, Santiago GA et al. Dengue virus: isolation, propagation, quantification, and storage. Curr Protoc Microbiol 2012 Chapter 15:Unit 15D.2 [View Article][PubMed]
     [Google Scholar]
  43. Loveday EK, Svinti V, Diederich S, Pasick J, Jean F. Temporal- and strain-specific host microRNA molecular signatures associated with swine-origin H1N1 and avian-origin H7N7 influenza A virus infection. J Virol 2012; 86:6109–6122 [View Article][PubMed]
     [Google Scholar]
  44. Loveday EK, Diederich S, Pasick J, Jean F. Human microRNA-24 modulates highly pathogenic avian-origin H5N1 influenza A virus infection in A549 cells by targeting secretory pathway furin. J Gen Virol 2015; 96:30–39 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000754
Loading
Moonlighting glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is required for efficient hepatitis C virus and dengue virus infections in human Huh-7.5.1 cells
J. Gen. Virol. 98, 977 (2017); https://doi.org/10.1099/jgv.0.000754
/content/journal/jgv/10.1099/jgv.0.000754
/content/journal/jgv/10.1099/jgv.0.000754
Loading

Data & Media loading...

Supplements

Supplementary File 1

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error